11.600
+0,00%
2026-10-19
Fundamental Analysis
15 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -94.6% | -52.9% | 0 / 3 | -0.0% | -7.03 pp | -5.50 pp | +6.4% | 0.28 | 10.81 | 1.543 | −0,0% | 24,0 | −77,9% | 10.81 | 8.19 | +32,0% |
| Pts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 11.600 (close price on 2026-10-19)EPS (TTM): 1.073
Financial charts
1.Revenue & growth
VND bn1.543Q2/26
1.Revenue & growth
VND bn1.543Q2/26
2.Profit & growth
VND bn4,94Q2/26
3.Profit mix (Penman)
VND bn198Q2/26
4.Margins & cost structure
%12.4%Q2/26
5.Returns & cash cycle
% · days8.2%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn3.887Q2/26
8.Funding & debt health
VND bn · times3.887Q2/26
9.Revenue backlog
VND bn20,1Q2/26
10.Valuation
times · %10,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %47Q2/26
Adjusted EPS growth, latest quarter
-94.6%
Average adjusted EPS growth, 3 quarters
-52.9%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26